{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:02:02Z","timestamp":1790222522921,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002649","name":"Yeungnam University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002649","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104806","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:33:02Z","timestamp":1789666382000},"page":"104806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dark proteome and emerging technologies for functional characterization and drug discovery"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-4558","authenticated-orcid":false,"given":"Md Azizul","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Danishuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104806_b0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41586-026-10459-x","article-title":"Expanding the human proteome with microproteins and peptideins","volume":"654","author":"Deutsch","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-genom-021623-081639","article-title":"Beyond the Human Genome Project: the age of complete human genome sequences and pangenome references","volume":"25","author":"Taylor","year":"2024","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.drudis.2026.104806_b0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800243","article-title":"Taxonomic landscape of the dark proteomes: whole-proteome scale interplay between structural darkness, intrinsic disorder, and crystallization propensity","volume":"18","author":"Hu","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2026.104806_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800061","article-title":"Intrinsically disordered proteins: the dark horse of the dark proteome","volume":"18","author":"Kulkarni","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2026.104806_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41580-023-00673-0","article-title":"The molecular basis for cellular function of intrinsically disordered protein regions","volume":"25","author":"Holehouse","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0959-440X(02)00289-0","article-title":"Coupling of folding and binding for unstructured proteins","volume":"12","author":"Dyson","year":"2002","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrm3920","article-title":"Intrinsically disordered proteins in cellular signalling and regulation","volume":"16","author":"Wright","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0045","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1038\/s41598-022-14382-9","article-title":"AlphaFold2 models indicate that protein sequence determines both structure and dynamics","volume":"12","author":"Guo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104806_b0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/nar\/gkae1091","article-title":"Updated resources for exploring experimentally-determined PDB structures and computed structure models at the RCSB Protein Data Bank","volume":"53","author":"Burley","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-4662-5_1","article-title":"Computational prediction of protein functional annotations","volume":"2947","author":"Kulmanov","year":"2025","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103029","article-title":"Atomistic molecular dynamics simulations of intrinsically disordered proteins","volume":"92","author":"Muhammedkutty","year":"2025","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202100211","article-title":"Microproteins: discovery, structure, and function","volume":"23","author":"Mohsen","year":"2023","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2026.104806_b0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41573-025-01220-6","article-title":"Targeting protein disorder: the next hurdle in drug discovery","volume":"24","author":"Lazar","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0075","article-title":"Harnessing noncanonical proteins for next-generation drug discovery and diagnosis","volume":"17","author":"Rajinikanth","year":"2025","journal-title":"WIREs Mech Dis"},{"key":"10.1016\/j.drudis.2026.104806_b0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tibs.2025.11.001","article-title":"Integrated approaches for discovery and functional annotation of proteins of unknown function","volume":"51","author":"Moitra","year":"2026","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.drudis.2026.104806_b0085","first-page":"269","article-title":"DisProt: intrinsic protein disorder annotation in 2020","volume":"48","author":"Hatos","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4382","article-title":"Liquid phase condensation in cell physiology and disease","volume":"357","author":"Shin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrm.2017.7","article-title":"Biomolecular condensates: organizers of cellular biochemistry","volume":"18","author":"Banani","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jmr.747","article-title":"Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling","volume":"18","author":"Uversky","year":"2005","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.drudis.2026.104806_b0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.04-1584rev","article-title":"The role of structural disorder in the function of RNA and protein chaperones","volume":"18","author":"Tompa","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104806_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrd.2018.14","article-title":"Unexplored therapeutic opportunities in the human genome","volume":"17","author":"Oprea","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrg3053","article-title":"The evolutionary origin of orphan genes","volume":"12","author":"Tautz","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104806_b0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03523","article-title":"Long non-coding RNAs as a source of new peptides","volume":"3","author":"Ruiz-Orera","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104806_b0130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41467-020-14500-z","article-title":"De novo emergence of adaptive membrane proteins from thymine-rich genomic sequences","volume":"11","author":"Vakirlis","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature11184","article-title":"Proto-genes and de novo gene birth","volume":"487","author":"Carvunis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0140","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3390\/cancers16152660","article-title":"Exploring the dark matter of human proteome: the emerging role of non-canonical open reading frame (ncORF) in cancer diagnosis, biology, and therapy","volume":"16","author":"Ge","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104806_b0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nchembio.1120","article-title":"Peptidomic discovery of short open reading frame-encoded peptides in human cells","volume":"9","author":"Slavoff","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0155","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/nar\/gkz734","article-title":"Alternative ORFs and small ORFs: shedding light on the dark proteome","volume":"48","author":"Orr","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41589-019-0425-0","article-title":"Accurate annotation of human protein-coding small open reading frames","volume":"16","author":"Martinez","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt.1833","article-title":"Overcoming barriers to membrane protein structure determination","volume":"29","author":"Bill","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104806_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BST20180267","article-title":"Cryo-EM in drug discovery","volume":"47","author":"Ceska","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.drudis.2026.104806_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm9506","article-title":"AI-based structure prediction empowers integrative structural analysis of human nuclear pores","volume":"376","author":"Mosalaganti","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2026.104806_b0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0200","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/17460441.2023.2246881","article-title":"The current role and evolution of X-ray crystallography in drug discovery and development","volume":"18","author":"Bijak","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0205","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/molecules25051030","article-title":"Protein X-ray crystallography and drug discovery","volume":"25","author":"Maveyraud","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104806_b0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s42004-025-01542-x","article-title":"NMR-driven structure-based drug discovery by unveiling molecular interactions","volume":"8","author":"Platzer","year":"2025","journal-title":"Commun Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmolb.2020.00009","article-title":"Methods for structural characterization of protein-protein complexes","volume":"7","author":"Purslow","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2026.104806_b0220","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1021\/acs.chemrev.1c01023","article-title":"NMR provides unique insight into the functional dynamics and interactions of intrinsically disordered proteins","volume":"122","author":"Camacho-Zarco","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2026.104806_b0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41592-023-01783-5","article-title":"Cryo-electron tomography on focused ion beam lamellae transforms structural cell biology","volume":"20","author":"Berger","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104806_b0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-022-00916-0","article-title":"Cryo-EM advances in RNA structure determination","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104806_b0235","doi-asserted-by":"crossref","first-page":"13989","DOI":"10.1021\/acs.chemrev.1c00837","article-title":"Membranes under the magnetic lens: a dive into the diverse world of membrane protein structures using cryo-EM","volume":"122","author":"Piper","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2026.104806_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.mser.2026.101192","article-title":"Accessing new dimensions in high-resolution materials exploration by cryo-electron microscopy","volume":"169","author":"Koralli","year":"2026","journal-title":"Mater Sci Eng R Rep"},{"key":"10.1016\/j.drudis.2026.104806_b0245","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10930-025-10296-3","article-title":"Combining cryo-EM with computational approaches to revolutionize structural biology","volume":"44","author":"Kim","year":"2025","journal-title":"Protein J"},{"key":"10.1016\/j.drudis.2026.104806_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127524","article-title":"Cryo-EM as a powerful tool for drug discovery","volume":"30","author":"Van Drie","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2026.104806_b0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-023-06788-w","article-title":"Disease-specific tau filaments assemble via polymorphic intermediates","volume":"625","author":"Lovestam","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0260","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0265","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41467-024-45920-w","article-title":"Structure of the p53 degradation complex from HPV16","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0270","doi-asserted-by":"crossref","first-page":"19551","DOI":"10.1021\/jacs.0c07565","article-title":"Folding of an intrinsically disordered iron-binding peptide in response to sedimentation revealed by cryo-EM","volume":"142","author":"Davidov","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2026.104806_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102950","article-title":"Deep learning for intrinsically disordered proteins: from improved predictions to deciphering conformational ensembles","volume":"89","author":"Erdos","year":"2024","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0280","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrm.2017.58","article-title":"Classification and function of small open reading frames","volume":"18","author":"Couso","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0285","article-title":"Boltz-2: towards accurate and efficient binding affinity prediction","author":"Passaro","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104806_b0290","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1021\/acs.jpcb.4c02507","article-title":"IDP-Bert: predicting properties of intrinsically disordered proteins using large language models","volume":"128","author":"Mollaei","year":"2024","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.drudis.2026.104806_b0295","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1038\/s41598-024-68565-7","article-title":"Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses","volume":"14","author":"Lopez-Cortes","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104806_b0300","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0305","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/s41592-024-02437-w","article-title":"De novo protein design with a denoising diffusion network independent of pretrained structure prediction models","volume":"21","author":"Liu","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104806_b0310","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1101\/gr.190603.115","article-title":"Genomic approaches for understanding the genetics of complex disease","volume":"25","author":"Lowe","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.drudis.2026.104806_b0315","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41594-023-01117-1","article-title":"CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames","volume":"30","author":"Zheng","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111884","article-title":"A large-scale sORF screen identifies putative microproteins involved in cancer cell fitness","volume":"28","author":"Schlesinger","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2026.104806_b0325","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2026.104806_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100719","article-title":"A massive proteogenomic screen identifies thousands of novel peptides from the human \u2018dark\u2019 proteome","volume":"23","author":"Cao","year":"2024","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2026.104806_b0335","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-22-1769","article-title":"Single-cell discovery and multiomic characterization of therapeutic targets in multiple myeloma","volume":"83","author":"Yao","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104806_b0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ebiom.2017.06.001","article-title":"Combined mass spectrometry imaging and top-down microproteomics reveals evidence of a hidden proteome in ovarian cancer","volume":"21","author":"Delcourt","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2026.104806_b0345","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41422-024-01059-3","article-title":"Comprehensive discovery and functional characterization of the noncanonical proteome","volume":"35","author":"Shi","year":"2025","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2026.104806_b0350","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1038\/s41467-025-61977-7","article-title":"Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases","volume":"16","author":"Xian","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.714687","article-title":"A comparative overview of epigenomic profiling methods","volume":"9","author":"Mehrmohamadi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0360","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0365","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s12276-025-01603-0","article-title":"Noncanonical association of EZH2 with E2F1 promotes tumor proliferation through chromatin remodeling","volume":"57","author":"Yoo","year":"2025","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104806_b0370","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinform Biol Insights"},{"key":"10.1016\/j.drudis.2026.104806_b0375","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.aay0262","article-title":"Pervasive functional translation of noncanonical human open reading frames","volume":"367","author":"Chen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0380","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","article-title":"Integrated proteogenomic characterization of clear cell renal cell carcinoma","volume":"179","author":"Clark","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104806_b0385","article-title":"Functional inference of gene regulation using single-cell multi-omics","volume":"2","author":"Kartha","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.drudis.2026.104806_b0390","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12551-022-00968-0","article-title":"Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases","volume":"14","author":"Coskuner-Weber","year":"2022","journal-title":"Biophys Rev"},{"key":"10.1016\/j.drudis.2026.104806_b0395","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0400","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acs.accounts.1c00065","article-title":"Reimagining druggability using chemoproteomic platforms","volume":"54","author":"Spradlin","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.drudis.2026.104806_b0405","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-biochem-060713-035708","article-title":"Enzyme inhibitor discovery by activity-based protein profiling","volume":"83","author":"Niphakis","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2026.104806_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114163","article-title":"A covalent strategy to target intrinsically disordered proteins: discovery of novel tau aggregation inhibitors","volume":"231","author":"Petri","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0415","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1021\/jasms.3c00281","article-title":"Characterization of molecular tweezer binding on alpha-synuclein with native top-down mass spectrometry and ion mobility-mass spectrometry reveals a mechanism for aggregation inhibition","volume":"34","author":"Lantz","year":"2023","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.drudis.2026.104806_b0420","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41592-026-03011-2","article-title":"AF2BIND: predicting small-molecule binding sites using the pair representation of AlphaFold2","volume":"23","author":"Gazizov","year":"2026","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104806_b0425","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41467-025-67127-3","article-title":"Benchmarking all-atom biomolecular structure prediction with FoldBench","volume":"17","author":"Xu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41467-024-55057-5","article-title":"Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics","volume":"16","author":"Biggs","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107217","article-title":"Proteasome activation: a novel strategy for targeting undruggable intrinsically disordered proteins","volume":"145","author":"Yu","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0440","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12915-025-02214-x","article-title":"Current perspectives in drug targeting intrinsically disordered proteins and biomolecular condensates","volume":"23","author":"Qin","year":"2025","journal-title":"BMC Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ht9030015","article-title":"Dark proteome database: studies on disorder","volume":"9","author":"Perdig\u00e3o","year":"2020","journal-title":"High Throughput"},{"key":"10.1016\/j.drudis.2026.104806_b0450","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2174\/1389450116666150722141119","article-title":"Untapped potential of disordered proteins in current druggable human proteome","volume":"17","author":"Hu","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.drudis.2026.104806_b0455","article-title":"From molecular descriptions to cellular functions of intrinsically disordered protein regions","volume":"5","author":"Chen","year":"2024","journal-title":"Biophys Rev (Melville)"},{"key":"10.1016\/j.drudis.2026.104806_b0460","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1021\/acs.jctc.4c01160","article-title":"Drugging disordered proteins by conformational selection to inform therapeutic intervention","volume":"21","author":"Bogin","year":"2025","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.drudis.2026.104806_b0465","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1042\/BST20210499","article-title":"Conformational ensembles of intrinsically disordered proteins and flexible multidomain proteins","volume":"50","author":"Thomasen","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.drudis.2026.104806_b0470","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-025-08618-7","article-title":"A cryptic pocket in CB1 drives peripheral and functional selectivity","volume":"640","author":"Rangari","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0475","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr0797","article-title":"Discovering cryptic pocket opening and binding of a stimulant derivative in a vestibular site of the 5-HT3A receptor","volume":"11","author":"Haloi","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104806_b0480","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3390\/ijms25094725","article-title":"Gaining insights into key structural hotspots within the allosteric binding pockets of protein kinases","volume":"25","author":"Bhujbal","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104806_b0485","doi-asserted-by":"crossref","first-page":"e02662","DOI":"10.1128\/mBio.02662-18","article-title":"Didehydro-cortistatin A inhibits HIV-1 by specifically binding to the unstructured basic region of Tat","volume":"10","author":"Mediouni","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.drudis.2026.104806_b0490","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2004.10.070","article-title":"Strategies for revealing lower abundance proteins in two-dimensional protein maps","volume":"815","author":"Ahmed","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.drudis.2026.104806_b0495","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s44321-024-00032-2","article-title":"Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in Kras(G12D)-driven tumors","volume":"16","author":"Santofimia-Casta\u00f1o","year":"2024","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2026.104806_b0500","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104806_b0505","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104806_b0510","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2026.104806_b0515","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0520","article-title":"Experimental methods to study the structure and dynamics of intrinsically disordered regions in proteins","volume":"7","author":"Maiti","year":"2024","journal-title":"Curr Res Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0525","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/acs.biochem.4c00248","article-title":"Fragment-based interrogation of the 14\u20133-3\/TAZ protein-protein interaction","volume":"63","author":"Andlovic","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2026.104806_b0530","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid-liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2026.104806_b0535","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"alpha-Synuclein aggregation nucleates through liquid-liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nat Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0540","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/BST20120125","article-title":"Intrinsic disorder in proteins: a challenge for (un)structural biology met by ion mobility-mass spectrometry","volume":"40","author":"Jurneczko","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.drudis.2026.104806_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109857","article-title":"Recent advances in de novo computational design and redesign of intrinsically disordered proteins and intrinsically disordered protein regions","volume":"752","author":"Saikia","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.drudis.2026.104806_b0550","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tibs.2007.10.003","article-title":"Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions","volume":"33","author":"Tompa","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.drudis.2026.104806_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2022.106769","article-title":"Intrinsically disordered proteins\/regions and insight into their biomolecular interactions","volume":"283","author":"Chakrabarti","year":"2022","journal-title":"Biophys Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0560","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0565","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ph16121649","article-title":"Revolutionizing drug targeting strategies: integrating artificial intelligence and structure-based methods in PROTAC development","volume":"16","author":"Danishuddin","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2026.104806_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102809","article-title":"Covalent fragment-based drug discovery for target tractability","volume":"86","author":"McCarthy","year":"2024","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0575","doi-asserted-by":"crossref","first-page":"16455","DOI":"10.1021\/acs.jmedchem.4c01288","article-title":"Structure-based optimization of a series of covalent, cell active Bfl-1 inhibitors","volume":"67","author":"Lucas","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104806_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116875","article-title":"E3 ubiquitin ligases and their therapeutic potential in disease management","volume":"236","author":"Madhukar","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104806_b0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2183\/pjab.96.016","article-title":"Molecular mechanisms of thalidomide and its derivatives","volume":"96","author":"Ito","year":"2020","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.drudis.2026.104806_b0590","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D2CS00116K","article-title":"Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders","volume":"51","author":"Yamamoto","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2026.104806_b0595","doi-asserted-by":"crossref","first-page":"15898","DOI":"10.1073\/pnas.1508380112","article-title":"Unexpected features of the dark proteome","volume":"112","author":"Perdigao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104806_b0600","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.aaz6695","article-title":"Unpicking the proteome in single cells","volume":"367","author":"Slavov","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104806_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2025.108251","article-title":"Hurdles and advancements in experimental membrane protein structural biology","volume":"217","author":"Bajaj","year":"2025","journal-title":"J Struct Biol"},{"key":"10.1016\/j.drudis.2026.104806_b0610","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/nar\/gkx1071","article-title":"MobiDB 3.0: more annotations for intrinsic disorder, conformational diversity and interactions in proteins","volume":"46","author":"Piovesan","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0615","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41588-024-02049-2","article-title":"Overcoming challenges associated with broad sharing of human genomic data","volume":"57","author":"LoTempio","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2026.104806_b0620","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41576-025-00820-7","article-title":"Genomic data sharing: you don't know what you've got (till it's gone)","volume":"26","author":"Holt","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104806_b0625","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41746-025-01503-7","article-title":"Bias recognition and mitigation strategies in artificial intelligence healthcare applications","volume":"8","author":"Hasanzadeh","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.drudis.2026.104806_b0630","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41467-025-67180-y","article-title":"Temporal trends in evidence supporting novel drug target discovery","volume":"17","author":"Falaguera","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104806_b0635","series-title":"Administrative Processing of Original Biologics License Applications (BLA) and New Drug Applications (NDA)","author":"US Food and Drug Administration (FDA)","year":"2026"},{"key":"10.1016\/j.drudis.2026.104806_b0640","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17460441.2025.2450636","article-title":"Advances in cryo-electron microscopy (cryoEM) for structure-based drug discovery","volume":"20","author":"Rubach","year":"2025","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.drudis.2026.104806_b0645","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nmeth.3144","article-title":"Proteogenomics: concepts, applications and computational strategies","volume":"11","author":"Nesvizhskii","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104806_b0650","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13040-017-0144-6","article-title":"The Dark Proteome Database","volume":"10","author":"Perdig\u00e3o","year":"2017","journal-title":"Biodata Mining"},{"key":"10.1016\/j.drudis.2026.104806_b0655","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/nar\/gkad928","article-title":"DisProt in 2024: improving function annotation of intrinsically disordered proteins","volume":"52","author":"Aspromonte","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0660","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/nar\/gkt1010","article-title":"IDEAL in 2014 illustrates interaction networks composed of intrinsically disordered proteins and their binding partners","volume":"42","author":"Fukuchi","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0665","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/nar\/gks1226","article-title":"D2P2: database of disordered protein predictions","volume":"41","author":"Oates","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0670","first-page":"403","article-title":"OpenProt: a more comprehensive guide to explore eukaryotic coding potential and proteomes","volume":"47","author":"Brunet","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0675","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12864-025-11301-w","article-title":"sORFdb \u2013 a database for sORFs, small proteins, and small protein families in bacteria","volume":"26","author":"Hahnfeld","year":"2025","journal-title":"BMC Genomics"},{"key":"10.1016\/j.drudis.2026.104806_b0680","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/nar\/gky1039","article-title":"MoonDB 2.0: an updated database of extreme multifunctional and moonlighting proteins","volume":"47","author":"Ribeiro","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104806_b0685","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/nar\/gkad1058","article-title":"ELM\u2014the Eukaryotic Linear Motif resource\u20142024 update","volume":"52","author":"Kumar","year":"2024","journal-title":"Nucleic Acids Res"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:31:46Z","timestamp":1790220706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002114"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104806","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dark proteome and emerging technologies for functional characterization and drug discovery","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104806"}}